Next Article in Journal
Selective Induction of Cancer Cell Death by Targeted Granzyme B
Next Article in Special Issue
Antibody-Directed Phototherapy (ADP)
Previous Article in Journal
Characterization of a Single Chain Fv Antibody that Reacts with Free Morphine
Article Menu

Export Article

Open AccessReview
Antibodies 2013, 2(1), 113-129;

Antibody Drug Conjugates as Cancer Therapeutics

Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA
Received: 24 December 2012 / Revised: 11 February 2013 / Accepted: 18 February 2013 / Published: 27 February 2013
(This article belongs to the Special Issue Antibody-Drug Conjugates)
Full-Text   |   PDF [336 KB, uploaded 27 February 2013]   |  


Monoclonal antibody (MAb) based therapies have achieved considerable success in oncology, primarily when used in combination with cytotoxic drugs. Antibody drug conjugates (ADCs) are a class of therapeutics that harness the antigen-selectivity of MAbs to deliver highly potent cytotoxic drugs to antigen-expressing tumor cells. The use of MAb directed delivery can confer a therapeutic index to highly potent cytotoxic drugs, increasing both the efficacy and safety of therapy. Although simple in concept, to achieve the design goal of improved therapeutic efficacy and reduced toxicity, each of the components of an ADC; the MAb, linker and drug need to considered in the context of the targeted antigen, the selectivity of antigen expression and the biology of the tumor type on which the target antigen is expressed. The characteristics of targets, MAbs, linkers and drugs being used in ADC design are discussed. View Full-Text
Keywords: antibody drug conjugate; ADC; immunoconjugate; antibody; cytotoxic; cancer; drug delivery antibody drug conjugate; ADC; immunoconjugate; antibody; cytotoxic; cancer; drug delivery

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Trail, P.A. Antibody Drug Conjugates as Cancer Therapeutics. Antibodies 2013, 2, 113-129.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top